The twelfth session of the National People's Congress put forward the concept of "medical old age security". The aim is to provide medical treatment for the sick and the elderly. China's medical pension and other people's livelihood improvement task is imminent, the urgent need to solve the problem of improving the efficiency of resource allocation, the implementation of the fine management and improve the quality of service and so on. That pension medical concept stocks which ?
Pensioner's Medical Concepts Stocks List
1, and good shares (300273)
Zhuhai and good medical equipment Co. * medical information and medical services. The company's principal products include oncology treatment equipment, including radionuclide treatment planning systems, cold polar radiofrequency oncology treatment machines, color ultrasound diagnostic puncture navigation systems, and body cavity thermal perfusion treatment machines. The company is also engaged in the business of medical molecular sieve oxygen generating equipment and engineering, as well as the business of distributing* routine diagnostic equipment and medical devices. The company mainly sells* its products in the domestic market.
2. UW Genetics (300676)
Shenzhen UW Genetics Co., Ltd. is a Chinese company primarily engaged in genomics-based diagnostics and research business. The company**s major products and services include basic research and clinical application services for reproductive health, basic science research services (genome sequencing, bioinformatics analysis and other multi-omics solutions, etc.), basic research and clinical application services for complex diseases and basic research and clinical application services for drugs. The company mainly serves domestic and international research schools, research institutes, independent laboratories, pharmaceutical companies, hospitals and medical check-up organizations.
3. Zhongyuan (300018)
Wuhan Zhongyuan Huadian Science and Technology Co., Ltd. is a Chinese company primarily engaged in the research and development, manufacturing, sales* and service business of products related to the intelligent recording and analysis of electric power systems, time synchronization, and integrated substation automation and distribution network automation. The company's business is organized into two main segments. The Power Transmission, Distribution and Control Equipment Manufacturing segment engages in the research, development, manufacture and sale* of power fault recording devices, time synchronization devices, integrated substation automation systems and distribution network automation equipment. The healthcare segment is primarily involved in the research, development and manufacture of medical information technology products and in vitro diagnostic equipment.
4, Dongcheng Pharmaceuticals (002675)
Yantai Dongcheng Pharmaceutical Group Co. is a Chinese company primarily engaged in the business of research and development, manufacturing and marketing* of pharmaceutical products. The company's main products are categorized into four groups, namely, APIs (APIs), nuclear pharmaceuticals, chemical pharmaceuticals and traditional Chinese medicines, which mainly include heparin sodium APIs, chondroitin sulfate, formulated products and nuclear pharmaceuticals. The company's products are sold in China's domestic and overseas markets.
5, Yuexin Health (002162)
Shanghai Yuexin Health Group Co, Ltd, (formerly known as: Shanghai Semiconductor Holding Co., Ltd.) is a Chinese company primarily engaged in the production and sale* of ceramic tiles. The company's principal products are glass tiles, including polished and non-polished tiles; glazed tiles, including crystal glazed tiles and ordinary glazed tiles; and special-purpose floor tiles. In addition, the company is engaged in the production and distribution* of eco-healthy building materials, warehouse leasing business, and medical business. The company operates primarily within China.
6. Tianmu Pharmaceuticals (600671)
Hangzhou Tianmushan Pharmaceuticals Co. is a Chinese company primarily engaged in the research and development, production and marketing* of pharmaceuticals and related healthcare products. The company is principally engaged in the manufacture of chemical raw materials, processing of traditional Chinese medicine tablets, and the manufacture of proprietary Chinese and western pharmaceutical preparations. The company's principal products are Pearl Mingshui Eye Drops, Compound Fresh Bamboo Leak Liquid, Amoxicillin Clavulanate Potassium Tablets, Hechu Dazao Capsules, Liuweidihuang Oral Liquid, Menthol and Mentholatum Oil, etc. The company's products are mainly sold in the PRC. The company's products are mainly sold within China.